Emerging Business Models in the Pharmaceutical Industries ...

Growth Factors
Growth Factors
-Effectiveness in Drugs
-Effectiveness in Drugs
-Growth in Technologies
-Growth in Technologies
-Outsourced Model
-Outsourced Model
-Biotech
-Biotech
Pharma Industry- Key Playing Fields
Market Share Drivers
Market Share Drivers
-Integrated Model
-Integrated Model
-Pre and Post Patent Strategies
-Pre and Post Patent Strategies
-Semi Blockbusters
-Semi Blockbusters
-Targeted Treatment Solutions
-Targeted Treatment Solutions
-Marketing Network
-Marketing Network
-New Revenue model
-New Revenue model
-R&D
-R&D
Key Playing
Field
Dynamic Shifts
Dynamic Shifts
-Parallel Trade
-Parallel Trade
-Generic vs. Patented
-Generic vs. Patented
-M&A
-M&A
-Branded vs. Unbranded
-Branded vs. Unbranded
Source: JSB Intelligence
Restraining Factors
Restraining Factors
-Limited Purchasing Capacity
-Limited Purchasing Capacity
-Reduced Productivity in R&D
-Reduced Productivity in R&D
-Reducing Net Selling Prices
-Reducing Net Selling Prices
-Reduced Consumption
-Reduced Consumption
Market Share Drivers
The short and long term strategies of
pharma companies play a crucial role in
deciding their market share. Short term
strategies aim at fighting patenting issues
and will have an immediate impact on
their market share in the coming years.
Long term strategies focus on
improvement in R&D, targeted treatment
solutions, biotech, and integrated network
models. Pharma companies are working
hard on long term issues even while
striving for larger market shares.
Market Growth Factors
The pharma market is being adversely
affected by declining R&D productivity,
high cost of commercialisation, reducing
selling rates, and lower consumption.
However, an unexplored market segment
has opened up due to advancement in
nano technologies, the need for more
effective drugs, and growth in the biotech
sector.
The key players are exploring efficient
ways to adopt the network model for R&D.
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players 8